BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1377527)

  • 1. Proteolytic balance and capillary morphogenesis in vitro.
    Pepper MS; Vassalli JD; Orci L; Montesano R
    EXS; 1992; 61():137-45. PubMed ID: 1377527
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteolytic balance and capillary morphogenesis.
    Pepper MS; Montesano R
    Cell Differ Dev; 1990 Dec; 32(3):319-27. PubMed ID: 1711917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
    Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.
    Koolwijk P; van Erck MG; de Vree WJ; Vermeer MA; Weich HA; Hanemaaijer R; van Hinsbergh VW
    J Cell Biol; 1996 Mar; 132(6):1177-88. PubMed ID: 8601593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the pericellular fibrinolytic system in angiogenesis.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen activators and angiogenesis.
    Mignatti P; Rifkin DB
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():33-50. PubMed ID: 8814993
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial function in thrombosis and thrombolysis.
    Sueishi K; Yasunaga C; Murata T; Kumamoto M; Nakagawa K; Kono S
    Jpn Circ J; 1992 Feb; 56(2):192-8. PubMed ID: 1372373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned media of carcinoma cells cultured in hypoxic microenvironment stimulate angiogenesis in vitro; relationship to basic fibroblast growth factor.
    Ishibashi H; Nakagawa K; Nakashima Y; Sueishi K
    Virchows Arch; 1995; 425(6):561-8. PubMed ID: 7535165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
    Pepper MS; Ferrara N; Orci L; Montesano R
    Biochem Biophys Res Commun; 1991 Dec; 181(2):902-6. PubMed ID: 1755866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.
    Koolwijk P; Kapiteijn K; Molenaar B; van Spronsen E; van der Vecht B; Helmerhorst FM; van Hinsbergh VW
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3359-67. PubMed ID: 11443212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
    Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
    J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method.
    Yasunaga C; Nakashima Y; Sueishi K
    Lab Invest; 1989 Dec; 61(6):698-704. PubMed ID: 2481153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta.
    Heidtmann HH; Havemann K; Schwartz-Albiez R
    Br J Cancer; 1992 Feb; 65(2):154-6. PubMed ID: 1310869
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the plasminogen activation system in angiogenesis and metastasis.
    Rabbani SA; Mazar AP
    Surg Oncol Clin N Am; 2001 Apr; 10(2):393-415, x. PubMed ID: 11382594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1992 Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro.
    Montesano R
    Eur J Clin Invest; 1992 Aug; 22(8):504-15. PubMed ID: 1385149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.